Advertisement

POZ September 2018

POZ September 2018

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:

ISSUU

Features

Grand Parents

Raising the children of parents lost to AIDS

Life Ball 2018

The annual fundraiser commemorates its 25th anniversary.

Editor’s Letter

Oriol R. Gutierrez

I’m Still Standing

This issue reflects on living and aging with HIV, as well as those it leaves behind.

POZ Q+A

AIDS Is Not Over

Visual AIDS marks 30 years of supporting the arts to fight HIV with new leadership and renewed focus.

POZ Planet

Stay in Touch

New groups help long-term survivors connect via workshops, social outings and spaghetti dinners!

Keeping HIV History Alive

You don’t have to be a long-term survivor to enjoy these reads.

The Art of Fighting HIV Criminalization

At a gallery, in print and during a Pride march

Let’s Stop HIV Stigma

A CDC campaign returns with new faces and a timeless message.

Voices

Now What?

Mark S. King reflects on the aftermath of his essay from the April/May 2018 issue of POZ. Below is an edited excerpt.

Will We?

After turning 70 years old, AIDS United policy fellow Ronald Johnson takes a thoughtful look back.

Spotlight

#WhatIsRememberedLives

A tour through @theaidsmemorial Instagram account’s tributes to life and loss.

Everyday

Everyday — September 2018

Here are some important dates in AIDS history.

Care And Treatment

Cancer Burden to Shift

The cancer rate of those living with HIV in the U.S. is expected to decline in the next decade.

HIV Treatment Halts Damage to Brain

AVR treatment halts brain damage and reduces damage.

Do Docs Navigate Conflicting HIV and Hep C Meds Well?

Research found that healthcare providers could do better at preventing drug interactions.

FDA OKs PrEP for Adolescents

PrEP is officially approved for adults and adolescents at risk for HIV who weigh at least 77 pounds.

Research Notes

Prevention: Antibody PrEP

Antibodies protect monkeys against SHIV.

Treatment: Integrase Inhibitors

People who take integrase inhibitors are less likely to stop them due to health issues.

Cure: Gene Editing

Scientists have used the CRISPR/Cas9 gene-editing method to snip out a key fragment of HIV’s genetic code from the cells of live rodents.

Concerns: Racial Disparities

Whites have a higher rate of successful HIV treatment.

Heroes

Aging With HIV

Lillibeth Gonzalez empowers people living with HIV.

Survey

Getting Older

Digital Edition

POZ September 2018

Read the digital edition!

Advertisement

Hot topics